J. Paul Davignon
- Molecular Biology
- Plant Science
- Complementary and alternative medicine top 10%
- Pharmacology
- Pharmacology top 10%
- Co-authors
- James C. CradockJoseph RubinCharles G. MoertelCharles W. YoungGregory SarnaViolante E. CurrieLarry K. KvolsThomas R. Fleming
- Topics
- Cannabis and Cannabinoid Research (3 papers)Poisoning and overdose treatments (2 papers)Safe Handling of Antineoplastic Drugs (2 papers)
- Journals
- New England Journal of MedicineJournal of Chromatography AInternational Journal of Pharmaceutics
- Partner nations
- United StatesNetherlandsRussia
In The Last Decade
J. Paul Davignon
15 papers receiving 290 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 68
- Plant Science 68
- Complementary and alternative medicine 61
- Pharmacology 48
- Pharmacology 43
Countries citing papers authored by J. Paul Davignon
This map shows the geographic impact of J. Paul Davignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Paul Davignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Paul Davignon more than expected).
Fields of papers citing papers by J. Paul Davignon
This network shows the impact of papers produced by J. Paul Davignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Paul Davignon. The network helps show where J. Paul Davignon may publish in the future.
Co-authorship network of co-authors of J. Paul Davignon
This figure shows the co-authorship network connecting the top 25 collaborators of J. Paul Davignon. A scholar is included among the top collaborators of J. Paul Davignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Paul Davignon. J. Paul Davignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 13 | |
| 3 | Identification of the patient at risk in the physician's office and drug management of dyslipoproteinemia. | 2 |
| 4 | 30 | |
| 5 | 14 | |
| 6 | 13 | |
| 7 | 163 | |
| 8 | 1 | |
| 9 | 9 | |
| 10 | 4 | |
| 11 | 2 | |
| 12 | 9 | |
| 13 | Intrathecal injections--a review of pharmaceutical factors. | 8 |
| 14 | 1 | |
| 15 | 33 | |
| 16 | Studies on a new hypotensive agent: bretylium tosylate. | 1 |
| 17 | Guanethidine administration in 28 hypertensive patients. | 5 |
About J. Paul Davignon
J. Paul Davignon is a scholar working on Toxicology, Occupational Therapy and Emergency Medicine, having authored 17 papers that have together received 318 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (3 papers), Poisoning and overdose treatments (2 papers) and Safe Handling of Antineoplastic Drugs (2 papers). The work is most often cited by research in Complementary and alternative medicine (61 citations), Complementary and Manual Therapy (12 citations) and Toxicology (18 citations). J. Paul Davignon has collaborated with scholars based in United States, Netherlands and Russia. Frequent co-authors include James C. Cradock, Joseph Rubin, Charles G. Moertel, Charles W. Young, Gregory Sarna, Violante E. Currie, Larry K. Kvols, Thomas R. Fleming, Robert Koch and Stephen E. Jones. Their work appears in journals such as New England Journal of Medicine, Journal of Chromatography A and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.